Abstract The aim of this study was to evaluate acyclic ligands which can be applied for labeling proteins such as monoclonal antibodies and their fragments with scandium radionuclides. Recently, scandium isotopes ( 47 Sc, 44 Sc) are more available and their properties are convenient for radiotherapy or PET imaging. They can be used together as ''matched pair'' in theranostic approach. Because proteins denaturize at temperature above 42°C, ligands which efficiently form complexes at room temperature, are necessary for labelling such biomolecules. For complexation of scandium radionuclides open chain ligands DTPA, HBED, BAPTA, EGTA, TTHA and deferoxamine have been chosen. We found that the ligands studied (except HBED) form strong complexes within 10 min and that the radiolabelling yield varies between 96 and 99 %. The complexes were stable in isotonic NaCl, but stability of 46 Sc-TTHA, 46 Sc-BAPTA and 46 Sc-HBED in PBS buffer was low, due to formation by Sc 3? stronger complexes with phosphates than with the studied ligands. From the radiolabelling studies with n.c.a. 47 Sc we can conclude that the most stable complexes are formed by the 8-dentate DTPA and EGTA ligands.
Introduction
Radionuclides emitting low and medium energy beta-particles and having several days half-life are attractive candidates for radioimmunotherapy. The most promising radioisotope in this category is 177 Lu, which has favourable decay characteristics, as e.g. half-life of 6.71 days.
This radionuclide can be produced in nuclear reactors by n,c reaction and is commercially available at high levels of specific activity and chemical purity.
Having large cross-section of 2090 b [1] , 177 Lu can be directly produced with a relatively high specific activity by neutron activation of 176 Lu (2.6 % of natural abundance). Nevertheless, some amount of stable 176 Lu cannot be avoided, which may cause some problems concerning receptor saturation with biomolecules labelled with stable isotope, especially when the number of receptors is limited. For this purpose an alternative production route via neutron capture, starting with enriched 176 Yb targets, has been demonstrated [2] [3] [4] . In this method, the isotopically enriched 176 Yb target undergoes the (n,c) reaction to produce 177 Yb, which subsequently decays by b --emission (T 1/ 2 = 1.9 h) to 177 Lu. However, this indirect production route requires difficult radiochemical separation of 177 Lu from the irradiated Yb 2 O 3 target. Taking into account that ytterbium and lutetium are neighbouring trivalent lanthanides and that the Yb/Lu mass ratio in the irradiated target can be as high as several thousand, separation is a very difficult task [2, 5, 6] .
The usefulness of other radionuclides, which may enhance the therapeutic effect of radiopharmaceuticals, should be also investigated. As a good alternative to application of carrier-free 177 Lu Lehenberger et al. [7] proposed application of reactor produced 161 Tb. The properties of this radionuclide are similar to those of 177 Lu, but separation from the target is considerably easier.
Application of 47 Sc, as an alternative radionuclide to 177 Lu, was proposed in earlier works [8] [9] [10] [11] . 47 Sc is a low energy b --emitter with a 3.35 days half-life, and shows a primary c-ray at 159 keV, which is suitable for imaging. It is important to mention that other scandium radionuclides, 43 Sc and 44 Sc, are also promising b ? -emitters, suitable for PET technique. Therefore, therapeutic 47 Sc together with diagnostic 44 Sc or 43 Sc can be used as ''matched pair'' in teranostic approach. Essential decay characteristics and production parameters for n.c.a. 47 Sc, 177 Lu and 161 Tb are presented in Table 1 .
The production method of highly active 47 Sc in a nuclear reactor was described by Mausner and coworkers [8, 12] 47 Sc has been investigated [11] . As shown in Table 1 , the advantage of 47 Sc production contrary to that of 177 Lu and 161 Tb, is relatively easy isolation of the radionuclide from the target, but the disadvantage is smaller cross-section of the nuclear reaction.
To date, only few reports concerning labelling studies with Sc radionuclides were published [14] [15] [16] [17] Authors of these papers concluded, that for labelling peptides, such as octreotide, the macrocyclic ligand 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA), is the most suitable. The stability of the DOTA complexes results from their kinetical inertness, therefore efficient labelling of DOTA-conjugates requires elevated (90°C) temperature. Due to its rather long half-life, 47 Sc can be also considered for preparation of alternative therapeutic agents with longer pharmacokinetics, such as 47 Sc-labelled proteins, as e.g. monoclonal antibodies, its fragments and nanobodies. Unfortunately, because proteins denaturize at temperature above 42°C, ligands other than DOTA, which form complexes at room temperature, are necessary for labelling such biomolecules. The acyclic chelators are not as kinetically stable as the macrocyclic chelators (DOTA, NOTA, TETA etc.), but formation of their complexes at room temperature is much faster. In this paper we report formation and stability studies on 47 Sc complexes with various acyclic polydentate ligands, which exhibit faster than DOTA kinetics of complex formation.
Experimental

Materials
The analytical grade reagents were used for radiochemical investigations. Water was obtained from a Millipore water purification system. Ammonium acetate and hydrofluoric acid (40 %) were purchased from Sigma-Aldrich. All resins (Chelex Ò 100, Dowex Ò 1X8, Dowex Ò 50WX4) were purchased in 100-200 mesh size from Dow Chemical.
The Ti-1.6 %. We have chosen the following acyclic ligands for the studies: 8-dentate diethylenetriaminepentaacetic acid (DTPA), 6-dentate N,N-bis(2-hydroxybenzyl)ethylenediamine-N,N-diacetic acid (HBED), 6-dentate 1,2-bis(o-aminophenoxy)ethane-N,N,N 0 ,N 0 -tetraacetic acid (BAPTA), 8-dentate ethylene glycol-bis(2-aminoethylether)-N,N, N 0 ,N 0 -tetraacetic acid (EGTA), 10-dentate triethylenetetraamine-N,N 0 ,N 00 ,N 000 -hexaacetic acid (TTHA) and deferoxamine (DFO). For comparison, cyclic 8-dentate ligand, the 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) has been chosen.
Radionuclides
For reasons of availability we used in preliminary experiments instead of 47 Sc, the longer lived 46 Sc radionuclide. The former is produced by fast neutron irradiation of the 47 Ti target, while 46 Sc can be produced in a simple way by 
. 47 Sc was quantitatively eluted using the 0.04 M HNO 3 ? 0.06 M HF solution. For additional purification the eluent was evaporated to dryness and the residue was dissolved in 0.1 M HNO 3 . Afterwards 47 Sc was adsorbed on cation exchange column Dowex Ò 50WX4 and finally eluted in two 1 ml fractions using 0.25 M ammonium acetate.
Syntheses of radiolabelled complexes
The experimental conditions for labelling, such as metalto-ligand molar ratio and time of reaction were optimized to achieve high complexation yield. The 46 Sc complexes were synthesized by mixing 164 nmol of carrier added 46 Sc in chloride form with aqueous solutions of chelators in various molar ligand-to-metal ratios (1/1, 2/1, 5/1, 10/1). In the case of n.c.a. 47 Sc 1 MBq was used and the ligand amount varied from 2 to 15 nmol. The complexes were prepared at room temperature at pH = 6.0 (20 mM acetate buffer). The radiolabelling yield was determined by thin layer chromatography (TLC) using silica gel plates (Polygram, Macherey-Nagel). The NH 3 /H 2 O (1/25) mixture was used as the mobile phase. The distribution of activity on paper strips was measured by cutting the paper into 1-cm pieces and counting in the NaI (Tl) well counter. The 46 Sccomplexes moved with the solvent front (R f = 1), while free 46 Sc remained at the starting point.
Stability of complexes
Stability of the 46,47 Sc acyclic complexes in isotonic NaCl solution and PBS buffer was assessed by adding 20 ll of radiocomplex solution to 500 ll of 0.9 % NaCl and 0.01 M PBS buffer. The solutions were incubated at 37°C and kinetics of the Sc complex dissociation was measured by taking aliquots of the NaCl and PBS solution at different time points and measuring the liberated 46 Sc by ITLC analysis.
Results and discussion
Radiolabelling and kinetics
As already mentioned, the cyclic polyamino- 47 Sc, we studied at first the kinetics of formation of Sc-DOTA complexes at room temperature. Figure 1 presents kinetics of scandium complexation by DOTA at 25 and 70°C.
As shown in Fig. 1 the kinetics of complexation at room temperature is slow, while increase of temperature to 70°C drastically increases kinetics of labelling. Therefore, macrocyclic ligands, like DOTA, are not suitable for labelling of thermal non-resistant molecules, like proteins. In the present work, we examined selected acyclic polyaminopolycarboxylate ligands, which form complexes with scandium cations more rapidly than does DOTA. The ligands demonstrating high affinity for 3? metal cations such as Fe 3? , Ga 3? and lanthanides were selected for our studies. Structures of the ligands are presented in Fig. 2 .
Kinetics of 46 Sc complexation by open chain ligands was studied, in contrary to the DOTA, only at room temperature (Fig. 3) . Comparison of Fig. 3 . with the Fig. 1 shows much faster labelling at room temperature, of the open chain ligands than of the cyclic DOTA. In the case of DTPA the labelling yield after 10 min reached more than 99 % of the equilibrium value, while in the case of DOTA achievements of about 90 % value required more than 20 h. However, as shows in Fig. 3 , the open chain ligand HBED seems, not to attain within 30 h equilibrium value.
The labelling yield of acyclic ligands with 46 Sc was studied by us at different metal-to-ligand molar ratios, see Table 2 . Our studies showed that at pH = 6.0 more than 96 % of 46 Sc was complexed with just 1:1 ligand-to-metal molar ratio.
In vitro stability studies For radionuclide therapy applications, radionuclides must remain associated with the targeting chelate-protein to avoid the toxicity released in their dissociation. As shown in Fig. 4 , all synthesized 46 Sc-complexes exhibited high stability in isotonic NaCl solution. After 120 h incubation in the NaCl solution more than 96 % of 46 Sc remained in complexed form. In 0.1 M PBS buffer 46 Sc-DTPA and 46 Sc-EGTA complexes were stable over the whole course of the experiment. Stability of 46 Sc-TTHA and 46 Sc-BABTA in PBS solution was very low due to replacement of ligands by phosphates in the first coordination sphere. In the case of 46 Sc-HBED slow decomposition of the complex was observed.
Labelling of the ligands with n.c.a. 47 Sc
The obtained results on complex formation and stability of 46 Sc complexes in PBS buffer shows that only Sc-DTPA and Sc-EGTA can be used as precursors for scandium radiopharmaceuticals. Therefore, we have chosen the two ligands for further studies with n.c.a. 47 Sc. Various concentrations of the ligands were investigated in order to evaluate their usability for binding 47 Sc to biomolecules. Radiolabelling was performed with quantities of the ligands from 2 to 15 nmol (Table 3) . For comparison, results of labelling the commonly used macrocyclic ligand DOTA [8] is presented in Table 4 .
From comparison of the Table 3 with the Table 4 one can conclude that both ligands, DTPA and EGTA, form complexes with n.c.a. 47 Sc, in lower amount of ligand than those formed by DOTA. Particularly in the case of EGTA, only 2 nmol of the ligand is sufficient to achieve labelling higher than 97 %. The reason is that EGTA and DTPA as a 8-dentate ligand, forms strong complexes by binding via four carboxylic oxygen atoms, two ether oxygen atoms and two nitrogen atoms (EGTA) [18] or five carboxylic and tree nitrogen (DTPA). As was reported by Thakur et al. [19] 
Conclusion
In this paper formation and in vitro stability of a series of polyamino-polycarboxylate ligands labelled with 46 Sc and 47 Sc has been studied. We found that acyclic ligands Fig. 4 Stability of 46 Sc-BABTA, 46 Sc-TTHA, 46 Sc-EGTA, 46 Sc-DTPA and 46 Sc-HBED complexes in 0.9 % NaCl and 0.1 M PBS buffer 46 Sc-BABTA and 46 Sc-HBED in PBS buffer was low, due to formation by Sc 3? stronger complexes with phosphates than with TTHA, BABTA and HBED. We have shown that when using n.c.a. 47 Sc only 2 nmol of the EGTA is sufficient to obtain labelling yield greater than 97 %. Therefore, Sc-EGTA is a promising moiety for coupling 47 Sc to proteins. However, biological studies on animal models are needed for evaluation the in vivo stability of radiometal-labelled chelates.
